25 May 2013
Keywords: bayer, gets, fda, ok, new, kogenate, received
Article | 03 July 2000
Bayer has received US Food and Drug Administration approval to market anew formulation of its anticoagulant drug Kogenate (recombinant factor ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.